home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410p.zip
/
M94A3217.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
3KB
|
52 lines
Document 3217
DOCN M94A3217
TI Serum cytokeratin 19 (CK 19) and pulmonary pneumocystosis (PCP) in HIV
infection.
DT 9412
AU Amiel C; Dousset B; Rabaud C; May T; Canton P; Service de Maladies
Infectieuses et Tropicales, CHU Nancy,; France.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):126 (abstract no. PA0123). Unique
Identifier : AIDSLINE ICA10/94369358
AB Epithelial cells of the respiratory tract have been shown to express CK
19, a component of the cytoskeleton now widely considered as a
characteristic and reliable tissue differentiation marker. As CK19 also
exists as a secreted form, we measured circulating level in HIV+
patients, to investigate the usefulness of this assay as marker of
opportunistic pulmonary infection and prognosis. We studied 81 HIV+
patients (76 men, 5 women), 22 to 48 years old, at different stages of
HIV infection, according to the CDC 87 classification: II/III n = 15;
IVC2 n = 31; IVC1 n = 31; IVD n = 3; IVE = 1. Samples from 30 age and
sex-matched healthy volunteers were used as controls. The levels of a
fragment of CK 19, CYFRA 21-1, were measured in serum samples using a
recently developed radioimmunometric assay. The two monoclonal
antibodies (KS 19-1 and BM 19-21) used in this assay recognize two
different epitopes of cytokeratin subunit 19 and are used in a sandwich
assay for CK 19 measurement. CK 19 serum levels observed in the control
group were lower than 2.6 ng/mL (mean 1.6 +/- 0.5 ng/mL). Similar value
were found in 40 HIV+ patients without any pulmonary opportunistic
infection history (mean 1.8 +/- 0.5 ng/mL). In 19 patients with history
of cured pulmonary disease (15 PCP, 2 Candidosis, 2 Cytomegalovirus
infection), CK 19 levels were in the same range than controls (0.06 to
2.2 ng/mL). 22 patients presenting with acute PCP were tested before
therapy initiation. CK 19 levels ranged between 0.06 and 16.8 ng/mL.
Only 7 out of these 22 patients had a dramatic increase of CK 19 ranging
between 3.4 to 16.8 ng/mL. All these 7 subjects exhibited severe PCP
with dyspnea (stage III or IV) and severe bilateral interstitial
syndrome on chest X-ray. In these 7 patients, PO2 pressure was below 50
mmHg and was negatively correlated with CK 19 level (p < 0.05). These 7
patients died 2 to 12 weeks later (mean 10 weeks). The 15 other patients
died 1 to 150 weeks later (mean 56 weeks) (p < 0.01). In conclusion, our
data suggest that in the course of HIV infection, the increase in CK 19
concentration is associated with severe forms of PCP and could be a
biological marker of pejorative prognosis.
DE Adult AIDS-Related Opportunistic Infections/*BLOOD/PHYSIOPATHOLOGY
Biological Markers/BLOOD Female Human HIV
Infections/*BLOOD/PHYSIOPATHOLOGY Keratin/*BLOOD Lung Diseases,
Fungal/*BLOOD/PHYSIOPATHOLOGY Male Middle Age Pneumocystis carinii
Infections/*BLOOD/PHYSIOPATHOLOGY Predictive Value of Tests Prognosis
Reference Values MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).